Corneal Myofibroma (Keloid) in a Young Patient with Neurofibromatosis Type 2

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Corneal Myofibroma (Keloid) in a Young Patient with Neurofibromatosis Type 2. / Zimmermann, Lisa; Reinhard, Thomas; Lange, Clemens; Heegaard, Steffen; Auw-Haedrich, Claudia.

In: Ocular Oncology and Pathology, Vol. 3, No. 4, 11.2017, p. 247-249.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Zimmermann, L, Reinhard, T, Lange, C, Heegaard, S & Auw-Haedrich, C 2017, 'Corneal Myofibroma (Keloid) in a Young Patient with Neurofibromatosis Type 2', Ocular Oncology and Pathology, vol. 3, no. 4, pp. 247-249. https://doi.org/10.1159/000457959

APA

Zimmermann, L., Reinhard, T., Lange, C., Heegaard, S., & Auw-Haedrich, C. (2017). Corneal Myofibroma (Keloid) in a Young Patient with Neurofibromatosis Type 2. Ocular Oncology and Pathology, 3(4), 247-249. https://doi.org/10.1159/000457959

Vancouver

Zimmermann L, Reinhard T, Lange C, Heegaard S, Auw-Haedrich C. Corneal Myofibroma (Keloid) in a Young Patient with Neurofibromatosis Type 2. Ocular Oncology and Pathology. 2017 Nov;3(4):247-249. https://doi.org/10.1159/000457959

Author

Zimmermann, Lisa ; Reinhard, Thomas ; Lange, Clemens ; Heegaard, Steffen ; Auw-Haedrich, Claudia. / Corneal Myofibroma (Keloid) in a Young Patient with Neurofibromatosis Type 2. In: Ocular Oncology and Pathology. 2017 ; Vol. 3, No. 4. pp. 247-249.

Bibtex

@article{6581434738d24fdfb3d9b5611f6a79c4,
title = "Corneal Myofibroma (Keloid) in a Young Patient with Neurofibromatosis Type 2",
abstract = "We present a 27-year-old male patient with neurofibromatosis type 2 (NF2), facial palsy, and lagophthalmos following acoustic neuroma removal and an impressing vascularized corneal tumor, which was excised. Histology showed a fibrous tumor with small vessels, and immunohistochemistry was positive for vimentin and negative for smooth muscle actin, S100, and GFAP. We assume a corneal myofibroma (keloid), which in this case rather represents a reactive lesion. This entity has not been described before in NF2 or in facial palsy-associated lagophthalmos in general.",
author = "Lisa Zimmermann and Thomas Reinhard and Clemens Lange and Steffen Heegaard and Claudia Auw-Haedrich",
year = "2017",
month = nov,
doi = "10.1159/000457959",
language = "English",
volume = "3",
pages = "247--249",
journal = "Ocular Oncology and Pathology",
issn = "2296-4681",
publisher = "S Karger AG",
number = "4",

}

RIS

TY - JOUR

T1 - Corneal Myofibroma (Keloid) in a Young Patient with Neurofibromatosis Type 2

AU - Zimmermann, Lisa

AU - Reinhard, Thomas

AU - Lange, Clemens

AU - Heegaard, Steffen

AU - Auw-Haedrich, Claudia

PY - 2017/11

Y1 - 2017/11

N2 - We present a 27-year-old male patient with neurofibromatosis type 2 (NF2), facial palsy, and lagophthalmos following acoustic neuroma removal and an impressing vascularized corneal tumor, which was excised. Histology showed a fibrous tumor with small vessels, and immunohistochemistry was positive for vimentin and negative for smooth muscle actin, S100, and GFAP. We assume a corneal myofibroma (keloid), which in this case rather represents a reactive lesion. This entity has not been described before in NF2 or in facial palsy-associated lagophthalmos in general.

AB - We present a 27-year-old male patient with neurofibromatosis type 2 (NF2), facial palsy, and lagophthalmos following acoustic neuroma removal and an impressing vascularized corneal tumor, which was excised. Histology showed a fibrous tumor with small vessels, and immunohistochemistry was positive for vimentin and negative for smooth muscle actin, S100, and GFAP. We assume a corneal myofibroma (keloid), which in this case rather represents a reactive lesion. This entity has not been described before in NF2 or in facial palsy-associated lagophthalmos in general.

U2 - 10.1159/000457959

DO - 10.1159/000457959

M3 - Journal article

C2 - 29344474

VL - 3

SP - 247

EP - 249

JO - Ocular Oncology and Pathology

JF - Ocular Oncology and Pathology

SN - 2296-4681

IS - 4

ER -

ID: 196344286